// company-profile

Arcutis Biotherapeutics, Inc.

ARQT
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings186Insiders21
// api This Arcutis Biotherapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 14 insiders purchased shares. Buying was led by Curran Terrie.

// 90-day insight

Over the last 90 days, Arcutis Biotherapeutics, Inc. insiders bought $0 (14 transactions) and sold $157K (6 transactions).

  • Most active insider: Welgus Howard G. with 12 transactions totaling $552K.
  • Largest single sale: $239K by Welgus Howard G. on Apr 1, 2026.
  • 50% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Arcutis Biotherapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$3.00B
QoQ change
-11.9%
Reporting period
2026-03-31
#1
SUVRETTA CAPITAL MANAGEMENT, LLC
CIK 1569064
$290.4M
12.3M shares
#2
Frazier Life Sciences Management, L.P.
CIK 1892134
$232.6M
9.9M shares
#3
Rubric Capital Management LP
CIK 1687509
$194.9M
8.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Welgus Howard G.ARQT
Sale10b5
635$25.67$16K
Jun 15, 2026Welgus Howard G.ARQT
Option Exercise10b5
822$6.52$5K
Jun 15, 2026Welgus Howard G.ARQT
Option Exercise10b5
2,255$8.63$19K
Jun 15, 2026LIN SUE-JEANARQT
Sale10b5
4,946$24.38$121K
Jun 15, 2026Welgus Howard G.ARQT
Option Exercise10b5
1,019$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.